FDA requirement for Safety data for ANDAs SDTM [Regulatives / Guidelines]

posted by DavidManteigas – Portugal, 2016-11-26 20:09 (3500 d 06:37 ago) – Posting: # 16815
Views: 5,328

Hi Sriraj,

Not surte if I understood your question.

According to FDA guidance, all data collected should be submitted, either safety, efficacy or other. Maybe you're talking about the datasets for the module 2.7. Not sure if, under the new requirements for data submission for ANDAs, those datasets should be submitted anyway. I would submit them anyway.

Regards,
David

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
319 visitors (0 registered, 319 guests [including 25 identified bots]).
Forum time: 03:46 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5